In particular, lung cancers and melanomas are among the tumors with the highest TMB, which has been independently associated with better response rates (RR), PFS and overall survival (OS) in patients treated with anti PD1/PDL1 immunotherapy [59]. Here, CD274 is linked to melanoma.